Cargando…
Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
In this review, we introduce current developments in induced pluripotent stem cells (iPSCs), site-specific nuclease (SSN)-mediated genome editing tools, and the combined application of these two novel technologies in biomedical research and therapeutic trials. The sustainable pluripotent property of...
Autores principales: | Chang, Chia-Yu, Ting, Hsiao-Chien, Su, Hong-Lin, Jeng, Jing-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038034/ https://www.ncbi.nlm.nih.gov/pubmed/29806481 http://dx.doi.org/10.1177/0963689718754560 |
Ejemplares similares
-
Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022) -
Differentiation of Human Pluripotent Stem Cells Into Specific
Neural Lineages
por: Chang, Chia-Yu, et al.
Publicado: (2021) -
Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery
por: Chang, Chia-Yu, et al.
Publicado: (2018) -
Robust Generation of Ready-to-Use Cryopreserved Motor Neurons from Human Pluripotent Stem Cells for Disease Modeling
por: Ting, Hsiao-Chien, et al.
Publicado: (2022) -
Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future
por: van den Brink, Lettine, et al.
Publicado: (2019)